HROW
Harrow Health Inc

3,359
Mkt Cap
$1.98B
Volume
2,575.00
52W High
$54.85
52W Low
$20.85
PE Ratio
-352.10
HROW Fundamentals
Price
$38.61
Prev Close
$53.59
Open
$44.65
50D MA
$48.43
Beta
1.38
Avg. Volume
551,403.15
EPS (Annual)
-$0.4903
P/B
42.21
Rev/Employee
$522,549.74
$1,377.31
Loading...
Loading...
Poll

Earnings Recap

• Reported GAAP EPS of $0.18 down -5.26% YoY • Reported revenue of $89.09M up 33.31% YoY • Harrow Health Inc expects full-year 2026 revenue guidance of $350M to $365M and full-year 2026 Adjusted EBITDA guidance of $80M to $100M.

Bullish

Harrow Health Inc achieved strong Q4 and full-year revenue growth, generated significant operating cash flow, and saw key products gaining traction. The company also plans strategic expansion and future product launches.

Bearish

Harrow Health Inc experienced a decrease in stockholders' equity and increased debt, alongside rising R&D and other expenses. Management also noted a need for improved clarity in financial guidance.

Latest HROW News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.